(Flip pages at the corners)
I. Message from the Editors-in-Chief
II. 2021 USA FDA-Approved Medications in Hematology
III. Editors Literature Selection:
- Thrombosis
- Hemostasis
- Anemia and other RBC Disorders
- Transfusion Medicine
- Lymphoma
- Plasma Cell Disorders
- Chronic Leukemia
- Myeloproliferative Neoplasm
- Acute Leukemia and Myelodysplastic Syndromes
- Bone Marrow Failure Disorders
- Gene and Cellular Therapy
- Hematopoietic Stem Cell Transplant
IV. Saudi Hematology News:
- SSBD Attained 2021 SCFHS Outstanding Healthcare Society Performance Award
V. Clinical Trials in Action
VI. Job Opening
VII. Membership Matters
VIII. Academic Calendar
